Oncolytic Virus Industry Research Report 2023

Oncolytic Virus Industry Research Report 2023


An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Highlights

The global Oncolytic Virus market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus.
The Oncolytic Virus market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oncolytic Virus market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Amgen
Shanghai Sunway Biotech

Product Type Insights

Global markets are presented by Oncolytic Virus type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Oncolytic Virus are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Oncolytic Virus segment by Type

Imlygic
Oncorine
Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Oncolytic Virus market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Oncolytic Virus market.
Oncolytic Virus segment by Application

Melanoma
Other Cancers

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Oncolytic Virus market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Oncolytic Virus industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oncolytic Virus manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oncolytic Virus by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oncolytic Virus in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Oncolytic Virus Market Size (2018-2029) & (US$ Million)
2.2.2 Global Oncolytic Virus Sales (2018-2029)
2.2.3 Global Oncolytic Virus Market Average Price (2018-2029)
2.3 Oncolytic Virus by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Imlygic
1.2.3 Oncorine
1.2.4 Others
2.4 Oncolytic Virus by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Melanoma
2.4.3 Other Cancers
3 Market Competitive Landscape by Manufacturers
3.1 Global Oncolytic Virus Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Oncolytic Virus Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Oncolytic Virus Revenue of Manufacturers (2018-2023)
3.4 Global Oncolytic Virus Average Price by Manufacturers (2018-2023)
3.5 Global Oncolytic Virus Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Oncolytic Virus, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Oncolytic Virus, Product Type & Application
3.8 Global Manufacturers of Oncolytic Virus, Date of Enter into This Industry
3.9 Global Oncolytic Virus Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Amgen
4.1.1 Amgen Company Information
4.1.2 Amgen Business Overview
4.1.3 Amgen Oncolytic Virus Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Amgen Oncolytic Virus Product Portfolio
4.1.5 Amgen Recent Developments
4.2 Shanghai Sunway Biotech
4.2.1 Shanghai Sunway Biotech Company Information
4.2.2 Shanghai Sunway Biotech Business Overview
4.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
4.2.5 Shanghai Sunway Biotech Recent Developments
5 Global Oncolytic Virus Market Scenario by Region
5.1 Global Oncolytic Virus Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Oncolytic Virus Sales by Region: 2018-2029
5.2.1 Global Oncolytic Virus Sales by Region: 2018-2023
5.2.2 Global Oncolytic Virus Sales by Region: 2024-2029
5.3 Global Oncolytic Virus Revenue by Region: 2018-2029
5.3.1 Global Oncolytic Virus Revenue by Region: 2018-2023
5.3.2 Global Oncolytic Virus Revenue by Region: 2024-2029
5.4 North America Oncolytic Virus Market Facts & Figures by Country
5.4.1 North America Oncolytic Virus Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Oncolytic Virus Sales by Country (2018-2029)
5.4.3 North America Oncolytic Virus Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Oncolytic Virus Market Facts & Figures by Country
5.5.1 Europe Oncolytic Virus Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Oncolytic Virus Sales by Country (2018-2029)
5.5.3 Europe Oncolytic Virus Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Oncolytic Virus Market Facts & Figures by Country
5.6.1 Asia Pacific Oncolytic Virus Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Oncolytic Virus Sales by Country (2018-2029)
5.6.3 Asia Pacific Oncolytic Virus Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Oncolytic Virus Market Facts & Figures by Country
5.7.1 Latin America Oncolytic Virus Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Oncolytic Virus Sales by Country (2018-2029)
5.7.3 Latin America Oncolytic Virus Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Oncolytic Virus Market Facts & Figures by Country
5.8.1 Middle East and Africa Oncolytic Virus Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Oncolytic Virus Sales by Country (2018-2029)
5.8.3 Middle East and Africa Oncolytic Virus Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Oncolytic Virus Sales by Type (2018-2029)
6.1.1 Global Oncolytic Virus Sales by Type (2018-2029) & (K Units)
6.1.2 Global Oncolytic Virus Sales Market Share by Type (2018-2029)
6.2 Global Oncolytic Virus Revenue by Type (2018-2029)
6.2.1 Global Oncolytic Virus Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Oncolytic Virus Revenue Market Share by Type (2018-2029)
6.3 Global Oncolytic Virus Price by Type (2018-2029)
7 Segment by Application
7.1 Global Oncolytic Virus Sales by Application (2018-2029)
7.1.1 Global Oncolytic Virus Sales by Application (2018-2029) & (K Units)
7.1.2 Global Oncolytic Virus Sales Market Share by Application (2018-2029)
7.2 Global Oncolytic Virus Revenue by Application (2018-2029)
6.2.1 Global Oncolytic Virus Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Oncolytic Virus Revenue Market Share by Application (2018-2029)
7.3 Global Oncolytic Virus Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Oncolytic Virus Value Chain Analysis
8.1.1 Oncolytic Virus Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Oncolytic Virus Production Mode & Process
8.2 Oncolytic Virus Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Oncolytic Virus Distributors
8.2.3 Oncolytic Virus Customers
9 Global Oncolytic Virus Analyzing Market Dynamics
9.1 Oncolytic Virus Industry Trends
9.2 Oncolytic Virus Industry Drivers
9.3 Oncolytic Virus Industry Opportunities and Challenges
9.4 Oncolytic Virus Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Oncolytic Virus Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Oncolytic Virus Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Oncolytic Virus Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Oncolytic Virus Revenue of Manufacturers (2018-2023)
Table 9. Global Oncolytic Virus Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Oncolytic Virus Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Oncolytic Virus Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Oncolytic Virus, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oncolytic Virus by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Amgen Company Information
Table 17. Amgen Business Overview
Table 18. Amgen Oncolytic Virus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Amgen Oncolytic Virus Product Portfolio
Table 20. Amgen Recent Developments
Table 21. Shanghai Sunway Biotech Company Information
Table 22. Shanghai Sunway Biotech Business Overview
Table 23. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Shanghai Sunway Biotech Oncolytic Virus Product Portfolio
Table 25. Shanghai Sunway Biotech Recent Developments
Table 26. Global Oncolytic Virus Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 27. Global Oncolytic Virus Sales by Region (2018-2023) & (K Units)
Table 28. Global Oncolytic Virus Sales Market Share by Region (2018-2023)
Table 29. Global Oncolytic Virus Sales by Region (2024-2029) & (K Units)
Table 30. Global Oncolytic Virus Sales Market Share by Region (2024-2029)
Table 31. Global Oncolytic Virus Revenue by Region (2018-2023) & (US$ Million)
Table 32. Global Oncolytic Virus Revenue Market Share by Region (2018-2023)
Table 33. Global Oncolytic Virus Revenue by Region (2024-2029) & (US$ Million)
Table 34. Global Oncolytic Virus Revenue Market Share by Region (2024-2029)
Table 35. North America Oncolytic Virus Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. North America Oncolytic Virus Sales by Country (2018-2023) & (K Units)
Table 37. North America Oncolytic Virus Sales by Country (2024-2029) & (K Units)
Table 38. North America Oncolytic Virus Revenue by Country (2018-2023) & (US$ Million)
Table 39. North America Oncolytic Virus Revenue by Country (2024-2029) & (US$ Million)
Table 40. Europe Oncolytic Virus Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Europe Oncolytic Virus Sales by Country (2018-2023) & (K Units)
Table 42. Europe Oncolytic Virus Sales by Country (2024-2029) & (K Units)
Table 43. Europe Oncolytic Virus Revenue by Country (2018-2023) & (US$ Million)
Table 44. Europe Oncolytic Virus Revenue by Country (2024-2029) & (US$ Million)
Table 45. Asia Pacific Oncolytic Virus Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Asia Pacific Oncolytic Virus Sales by Country (2018-2023) & (K Units)
Table 47. Asia Pacific Oncolytic Virus Sales by Country (2024-2029) & (K Units)
Table 48. Asia Pacific Oncolytic Virus Revenue by Country (2018-2023) & (US$ Million)
Table 49. Asia Pacific Oncolytic Virus Revenue by Country (2024-2029) & (US$ Million)
Table 50. Latin America Oncolytic Virus Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 51. Latin America Oncolytic Virus Sales by Country (2018-2023) & (K Units)
Table 52. Latin America Oncolytic Virus Sales by Country (2024-2029) & (K Units)
Table 53. Latin America Oncolytic Virus Revenue by Country (2018-2023) & (US$ Million)
Table 54. Latin America Oncolytic Virus Revenue by Country (2024-2029) & (US$ Million)
Table 55. Middle East and Africa Oncolytic Virus Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. Middle East and Africa Oncolytic Virus Sales by Country (2018-2023) & (K Units)
Table 57. Middle East and Africa Oncolytic Virus Sales by Country (2024-2029) & (K Units)
Table 58. Middle East and Africa Oncolytic Virus Revenue by Country (2018-2023) & (US$ Million)
Table 59. Middle East and Africa Oncolytic Virus Revenue by Country (2024-2029) & (US$ Million)
Table 60. Global Oncolytic Virus Sales by Type (2018-2023) & (K Units)
Table 61. Global Oncolytic Virus Sales by Type (2024-2029) & (K Units)
Table 62. Global Oncolytic Virus Sales Market Share by Type (2018-2023)
Table 63. Global Oncolytic Virus Sales Market Share by Type (2024-2029)
Table 64. Global Oncolytic Virus Revenue by Type (2018-2023) & (US$ Million)
Table 65. Global Oncolytic Virus Revenue by Type (2024-2029) & (US$ Million)
Table 66. Global Oncolytic Virus Revenue Market Share by Type (2018-2023)
Table 67. Global Oncolytic Virus Revenue Market Share by Type (2024-2029)
Table 68. Global Oncolytic Virus Price by Type (2018-2023) & (US$/Unit)
Table 69. Global Oncolytic Virus Price by Type (2024-2029) & (US$/Unit)
Table 70. Global Oncolytic Virus Sales by Application (2018-2023) & (K Units)
Table 71. Global Oncolytic Virus Sales by Application (2024-2029) & (K Units)
Table 72. Global Oncolytic Virus Sales Market Share by Application (2018-2023)
Table 73. Global Oncolytic Virus Sales Market Share by Application (2024-2029)
Table 74. Global Oncolytic Virus Revenue by Application (2018-2023) & (US$ Million)
Table 75. Global Oncolytic Virus Revenue by Application (2024-2029) & (US$ Million)
Table 76. Global Oncolytic Virus Revenue Market Share by Application (2018-2023)
Table 77. Global Oncolytic Virus Revenue Market Share by Application (2024-2029)
Table 78. Global Oncolytic Virus Price by Application (2018-2023) & (US$/Unit)
Table 79. Global Oncolytic Virus Price by Application (2024-2029) & (US$/Unit)
Table 80. Key Raw Materials
Table 81. Raw Materials Key Suppliers
Table 82. Oncolytic Virus Distributors List
Table 83. Oncolytic Virus Customers List
Table 84. Oncolytic Virus Industry Trends
Table 85. Oncolytic Virus Industry Drivers
Table 86. Oncolytic Virus Industry Restraints
Table 87. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Oncolytic VirusProduct Picture
Figure 5. Global Oncolytic Virus Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Oncolytic Virus Market Size (2018-2029) & (US$ Million)
Figure 7. Global Oncolytic Virus Sales (2018-2029) & (K Units)
Figure 8. Global Oncolytic Virus Average Price (US$/Unit) & (2018-2029)
Figure 9. Imlygic Product Picture
Figure 10. Oncorine Product Picture
Figure 11. Others Product Picture
Figure 12. Melanoma Product Picture
Figure 13. Other Cancers Product Picture
Figure 14. Global Oncolytic Virus Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Oncolytic Virus, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Oncolytic Virus, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Oncolytic Virus Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Oncolytic Virus Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Oncolytic Virus Sales by Region in 2022
Figure 21. Global Oncolytic Virus Revenue by Region in 2022
Figure 22. North America Oncolytic Virus Market Size by Country in 2022
Figure 23. North America Oncolytic Virus Sales Market Share by Country (2018-2029)
Figure 24. North America Oncolytic Virus Revenue Market Share by Country (2018-2029)
Figure 25. United States Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Oncolytic Virus Market Size by Country in 2022
Figure 28. Europe Oncolytic Virus Sales Market Share by Country (2018-2029)
Figure 29. Europe Oncolytic Virus Revenue Market Share by Country (2018-2029)
Figure 30. Germany Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Oncolytic Virus Market Size by Country in 2022
Figure 36. Asia Pacific Oncolytic Virus Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Oncolytic Virus Revenue Market Share by Country (2018-2029)
Figure 38. China Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Oncolytic Virus Market Size by Country in 2022
Figure 48. Latin America Oncolytic Virus Sales Market Share by Country (2018-2029)
Figure 49. Latin America Oncolytic Virus Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Oncolytic Virus Market Size by Country in 2022
Figure 54. Middle East and Africa Oncolytic Virus Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Oncolytic Virus Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Oncolytic Virus Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Oncolytic Virus Sales Market Share by Type (2018-2029)
Figure 60. Global Oncolytic Virus Revenue Market Share by Type (2018-2029)
Figure 61. Global Oncolytic Virus Price (US$/Unit) by Type (2018-2029)
Figure 62. Global Oncolytic Virus Sales Market Share by Application (2018-2029)
Figure 63. Global Oncolytic Virus Revenue Market Share by Application (2018-2029)
Figure 64. Global Oncolytic Virus Price (US$/Unit) by Application (2018-2029)
Figure 65. Oncolytic Virus Value Chain
Figure 66. Oncolytic Virus Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Oncolytic Virus Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings